The Faculty
PharmaVentures' training workshops are delivered by a group of highly experienced individuals including Fintan Walton and Nigel Borshell.
Fintan Walton (CEO And Founder)
Dr Walton is the Founder and CEO of PharmaVentures. He was educated at the University of Michigan (US) and Trinity College (Dublin, Ireland), and subsequently he gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992). As an entrepreneur, Dr Walton co-founded CONNECT Pharma in 1992, a company focused on assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making including strategic alliances, Mergers & Acquisitions and equity financing. In 1997 the company became PharmaVentures. His company has worked with blue chip clients on a global basis, delivering more than 500 assignments for companies in 37 countries. Clients have included major pharmaceutical and biotechnology companies as well as diversified chemical corporations, medical device, generic and OTC companies. His clients have included major banks, investment/merchant banks, and private equity and venture capital groups. Although Dr Walton’s main focus is his role as Chief Executive Officer of PharmaVentures, he is available for some consultancy assignments.
Nigel Borshell, BSc. (Vice President)
Nigel has over 30 years experience in Life Sciences including senior international commercial management roles in diagnostics and biotechnology gained at drug testing specialists Syva Company, Hoechst’s Behring division, US diagnostics giant Dade Behring, and as European Business Development Director for California-based Cepheid. Nigel is the author of numerous Pharmaceutical/Biotech Industry reports, papers and articles. At PharmaVentures, Nigel specialises in valuation methodologies, deal structure modelling, and pricing policies.
